Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

46.52
Delayed Data
As of May 03
 -3.22 / -6.47%
Today’s Change
33.50
Today|||52-Week Range
126.35
-28.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues25.1M25.5M65.4M59.1M
 
 
 
 
 
Depreciation And Amortization1.2M1.4M1.4M3.3M
 
 
 
 
 
 
Operating ExpensesGross Income23.9M------
 
 
General Expenses46.9M63.0M118.1M174.5M
 
 
 
 
 
Research And Development41.0M54.5M100.4M141.8M
 
 
 
 
 
Total Operating Expenses48.1M64.4M119.5M177.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.0M-38.9M-54.1M-118.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.9M-38.8M-53.9M-117.7M
 
 
 
 
 
Income Taxes-2.8M-579.0K-426.0K0.00
 
 
 
 
Preferred Dividend0.00-4.2M0.000.00
 
 
Net Income-20.1M-39.4M-53.5M-117.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.1M15.4M33.7M37.4M
 
 
 
 
 
Shares To Calculate EPS Diluted23.1M15.4M33.7M37.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.18-$2.83-$1.59-$3.15
 
 
 
 
 
EPS Diluted-$0.87-$2.83-$1.59-$3.15